Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Israel shares higher at close of trade; TA 25 up 0.12%

Published 21/03/2016, 02:00 am
Israel shares higher at close of trade; TA 25 up 0.12%
TEVA
-
TA35
-
TEREAL
-
NWMDp
-
NICE
-
AZRG
-
TABLUTECHGLB
-
BIOMED
-
OPK
-
PRGO
-

Investing.com – Israel equities were higher at the close on Sunday, as gains in the Biomed, Technology and Real Estate sectors propelled shares higher.

At the close in Tel Aviv, the TA 25 added 0.12%.

The biggest gainers of the session on the TA 25 were OPKO Health Inc (TA:OPK), which rose 4.72% or 190 points to trade at 4215 at the close. Nice (TA:NICE) added 1.87% or 460 points to end at 25010 and Azrieli Group (TA:AZRG) was up 1.61% or 240 points to 15190 in late trade.

Biggest losers included Teva (TA:TEVA), which lost 1.69% or 360 points to trade at 20920 in late trade. Perrigo (TA:PRGO) declined 1.28% or 640 points to end at 49470 and Delek Drilling LP (TA:DEDRp) shed 1.16% or 14 points to 1191.

Advancing stocks outnumbered falling ones by 215 to 100 and 138 ended unchanged on the Tel Aviv Stock Exchange.

In commodities trading, Crude oil for April delivery was unchanged 0.00% or 0.00 to $41.14 a barrel. Meanwhile, Brent oil for delivery in May fell 0.29% or 0.12 to hit $41.42 a barrel, while the April Gold contract fell 0.71% or 9.00 to trade at $1256.00 a troy ounce.

USD/ILS was up 0.10% to 3.8542, while EUR/ILS fell 0.32% to 4.3439.

The US Dollar Index was up 0.32% at 95.07.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.